Search results for "Musca"

showing 10 items of 300 documents

Neuronal Growth and Behavioral Alterations in Mice Deficient for the Psychiatric Disease-Associated Negr1 Gene

2018

Neuronal growth regulator 1 (NEGR1), a member of the immunoglobulin superfamily cell adhesion molecule subgroup IgLON, has been implicated in neuronal growth and connectivity. In addition, genetic variants in or near the NEGR1 locus have been associated with obesity and more recently with learning difficulties, intellectual disability and psychiatric disorders. However, experimental evidence is lacking to support a possible link between NEGR1, neuronal growth and behavioral abnormalities. Initial expression analysis of NEGR1 mRNA in C57Bl/6 wildtype (WT) mice by in situ hybridization demonstrated marked expression in the entorhinal cortex (EC) and dentate granule cells. In co-cultures of co…

cognition0301 basic medicinehippocampusMorris water navigation taskIn situ hybridizationneuronal connectivityHippocampal formationBiologylcsh:RC321-57103 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineNeurotransmitter receptoraxon growthMuscarinic acetylcholine receptorlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryMolecular Biologyentorhinal cortexNeuronal growth regulator 1Dentate gyrusEntorhinal cortexCell biology030104 developmental biologynervous systemcell adhesion molecule030217 neurology & neurosurgeryFrontiers in Molecular Neuroscience
researchProduct

Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on β-blockers

2015

Introduction: The TONADO studies (NCT01431274; NCT01431287) established the efficacy and safety of a new once-daily fixed-dose combination (FDC) with tiotropium (T), a long-acting muscarinic antagonist, and olodaterol (O), a long-acting β 2 -agonist, for the treatment of COPD. This post hoc analysis evaluates T+O safety in the subgroup of patients (pts) receiving β-blockers (BBs) in these studies. Methods: These were randomised, double-blind, parallel-group, 52-week, Phase III trials comparing T+O FDC (2.5/5 µg; 5/5 µg) with the monocomponents. Adverse events (AEs) and serious AEs (SAEs) were recorded and SAEs independently adjudicated. Pooled safety data from pts receiving BBs at baseline …

congenital hereditary and neonatal diseases and abnormalitiesCOPDmedicine.medical_specialtybusiness.industryIncidence (epidemiology)Fixed-dose combinationOlodaterolMuscarinic antagonistmedicine.diseasechemistry.chemical_compoundchemistryInternal medicinePost-hoc analysisMedicineIn patientbusinessAdverse effectmedicine.drug5.1 Airway Pharmacology and Treatment
researchProduct

Regulation of serotonin release from the intestinal mucosa.

1991

Summary In the mammalian intestine serotonin (5-hydroxytryptamine, 5-HT) is present in high concentrations in the enterochromaffin cells. The release of 5-HT from the intestinal mucosa is regulated by a complex pattern of neuronal and humoral inputs to the enterochromaffin cells. The enterochromaffin cells appear to be endowed with different inhibitory ( α 2 -adrenoceptors, GABA A - and GABA B -receptors, histamine H 3 -receptors, receptors for vasoactive intestinal polypeptide and somatostatin) as well as stimulatory receptors ( β -adrenoceptors, muscarine and nicotine receptors). The physiological significance of this complex system of receptors is suggested by experiments which demonstra…

endocrine systemmedicine.medical_specialtySerotoninVasoactive intestinal peptideBiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIntestinal mucosaInternal medicinemedicineAnimalsHumansIntestinal MucosaReceptor5-HT receptor030304 developmental biologyPharmacology0303 health sciencesMuscarine3. Good healthEndocrinologychemistryEnterochromaffin cellSerotonin030217 neurology & neurosurgeryAcetylcholinemedicine.drugPharmacological research
researchProduct

Temporal resolution and temporal transfer properties: gabaergic and cholinergic mechanisms.

2007

Temporal resolution is a basic property of the visual system and critically depends upon retinal temporal coding properties which are also of importance for directional coding. Whether the temporal coding properties for directional coding derive form inherent properties or critically depend upon the temporal coding mechanisms is unclear. Here, the influence of acetylcholine and GABA upon photopic temporal coding was investigated in goldfish, using flicker stimuli, in a behavioral and an electrophysiological (ERG) approach. The goldfish temporal resolution ability decreased from more than 90% correct choices at 20 Hz flicker frequency to about 65% at 45 Hz flicker frequency with a flicker fu…

genetic structuresPhysiologyGABA AgentsCholinergic AgentsFlicker fusion thresholdChoice BehaviorRetinaFlicker FusionGoldfishMuscarinic acetylcholine receptormedicineElectroretinographyAnimalsgamma-Aminobutyric AcidAcetylcholine receptorBehavior AnimalDose-Response Relationship DrugChemistryAdaptation OcularFlickerSensory SystemsAcetylcholineNicotinic agonistTemporal resolutionCholinergicNeuroscienceAcetylcholinePhotic Stimulationmedicine.drugVisual neuroscience
researchProduct

Synthese und pharmakologische Wirkung von carbocyclischen Muskarinanalogen

1974

Als carbocyclische Muskarinanaloga wurden das (3-Hydroxycyclopentylmethyl)trimethyl-ammonium-jodid und dessen Acetat dargestellt und am isolierten Ileum des Meerschweinchens untersucht. Synthesis and Pharmacological Activity of Carbocyclic Analogs of Muscarine As carbocyclic analogs of muscarine (3-hydroxycyclopentylmethyl)trimethylammonium iodide and (3-acetoxycyclopentylmethyl)trimethylammonium iodide were synthesized and tested on the isolated guinea pig ileum.

inorganic chemicalschemistry.chemical_classificationMuscarineChemistryStereochemistryIodidetechnology industry and agriculturePharmaceutical ScienceBiological activityIleumchemistry.chemical_compoundmedicine.anatomical_structureDrug Discoverymedicinelipids (amino acids peptides and proteins)Guinea pig ileumArchiv der Pharmazie
researchProduct

Tiotropium in asthma: Back to the future of anticholinergic treatment

2017

Abstract Asthma is among the most common chronic diseases worldwide; however, despite progresses in the understanding of the patho-physiological mechanisms and advances in the development of new therapeutic options and strategies, the disease remains uncontrolled in a not trivial proportion of subjects. Thus, the need of new molecules to treat the underlying biological and functional abnormalities and to control symptoms is strongly advocated by clinicians. In this scenario, the most recent GINA guidelines have included the use of tiotropium bromide in the most severe and uncontrolled forms of the disease, in addition to treatment with inhaled corticosteroid plus long acting beta adrenergic…

lcsh:Immunologic diseases. AllergyEndotypeAllergymedicine.medical_specialtyExacerbationmedicine.drug_classPopulationAntimuscarinicImmunologyReviewDiseaseAnticholinergicSettore MED/10 - Malattie Dell'Apparato RespiratorioEndotype03 medical and health sciences0302 clinical medicineControlmedicineAnticholinergicImmunology and Allergy030212 general & internal medicineeducationIntensive care medicineMolecular BiologyAsthmaeducation.field_of_studybusiness.industryTiotropiumExacerbationTiotropium bromidemedicine.diseaseAsthmaPhenotype030228 respiratory systemBronchodilationlcsh:RC581-607businessmedicine.drug
researchProduct

ChemInform Abstract: Regioisomeric 5(3)-Aminomethyl-3(5)-phenylisoxazoles: Synthesis, Spectroscopic Discrimination, and Muscarinic Activity.

2010

The regioselective synthesis of isomeric 5(3)-aminomethyl-3(5)-phenyl isoxazoles using different methods is described. Spectroscopic data, especially mass spectrometric fragmentation, were used to identify and characterize the regioisomers. The muscarinic activity of these isoxazoles was assayed on isolated guinea-pig ileum and atria as well as on isolated rabbit vas deferens. Regioisomere 5(3)-Aminomethyl-3(5)-phenyl-isoxazole: Synthese, spektroskopische Unterscheidung und muskarinische Aktivitat Es werden verschiedene Verfahren zur regioselektiven Darstellung von 5(3)-Aminomethyl-3(5)-phenyl-isoxazolen beschrieben, die anhand ihrer spektroskopischen Daten, insbesondere der massenspektrosk…

medicine.anatomical_structureStereochemistryChemistryMuscarinic acetylcholine receptorStructural isomerVas deferensmedicineGeneral MedicineMass spectrometricChemInform
researchProduct

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

2007

Abstract Antimuscarinic therapy is the primary treatment for overactive bladder. Long-term persistence with the therapy can be problematical, and has been linked to both efficacy and tolerability. A number of specific contributory factors to poor persistence can be identified, such as adverse effects of medication, insufficient beneficial effects, inadequate follow-up after initiation of therapy (poor motivation), and unmet or unrealistic expectations (poor communication between the patient and physician). Open-label studies on antimuscarinics overestimate the real-life persistence, which can lead to unrealistic expectations of the physician. Dose flexibility has improved patient compliance…

medicine.medical_specialtyAntimuscarinic Agentbusiness.industryTransdermal patchUrologymedicine.diseasePatient satisfactionTolerabilityQuality of lifeOveractive bladderPillPhysical therapyMedicineAdverse effectbusinessIntensive care medicineEuropean Urology Supplements
researchProduct

Altered receptor binding densities in experimental antiphospholipid syndrome despite only moderately enhanced autoantibody levels and absence of beha…

2013

Abstract Experimental antiphospholipid syndrome (eAPS) in Balb/c mice causes neuropsychiatric abnormalities including hyperactivity, increased explorative behavior and cognitive deficits. Recently, we have demonstrated that these behavioral changes were linked to an upregulation of serotonergic 5-HT1A receptor binding densities in cortical and hippocampal regions while excitatory and inhibitory neurotransmitter receptors remain largely unchanged. To examine whether the observed behavioral features depend on a critical antibody concentration, mice with only moderately enhanced antiphospholipid antibodies (aPL), about 50–80% of high levels, were analyzed and compared to controls. The staircas…

medicine.medical_specialtyBehavior AnimalChemistryGABAA receptorImmunologyHematologyAMPA receptorNeuropsychological TestsAntiphospholipid SyndromeSerotonergicReceptors NeurotransmitterDisease Models AnimalMiceEndocrinologyNeurotransmitter receptorInternal medicineMuscarinic acetylcholine receptormedicineAnimalsImmunology and AllergyNMDA receptorFemaleReceptor5-HT receptorAutoantibodiesImmunobiology
researchProduct

Mucosa-dependent muscarinic liberation of prostaglandins from rat isolated trachea.

1995

1. The present study examined whether cholinoceptor stimulation modulates the release of arachidonic acid-derived mediators from rat isolate tracheae. 2. Tracheae were preincubated with [3H]-arachidonic acid and the outflow of 3H-compounds was determined. Acetylcholine and the muscarinic agonist, carbachol but not nicotine, increased the rate of tritium outflow maximally by about 30%. The M3 receptor-preferring antagonist rho-fluoro-hexahydrosiladiphenidol was more effective than pirenzepine and methoctramine in antagonizing the effect of acetylcholine. 3. High performance liquid chromatography analysis (methanol gradient) of the released 3H-compounds showed that one peak, co-eluting with […

medicine.medical_specialtyCarbacholAcetonitrilesMuscarinic AntagonistsIn Vitro TechniquesMuscarinic AgonistsMuscarinic agonistRats Sprague-Dawleychemistry.chemical_compoundPiperidinesInternal medicineMuscarinic acetylcholine receptormedicineMethoctramineAnimalsDrug InteractionsAcetylcholine receptorPharmacologyArachidonic AcidDose-Response Relationship DrugMuscarinic acetylcholine receptor M1PirenzepineAcetylcholineRatsTracheaEndocrinologychemistryProstaglandinslipids (amino acids peptides and proteins)FemaleAcetylcholinemedicine.drugResearch Article
researchProduct